Lewis Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.4M Buy
5,201
+300
+6% +$74.9K 2.18% 8
2023
Q2
$1.09M Sell
4,901
-100
-2% -$23.2K 1.56% 15
2023
Q1
$1.21M Sell
5,001
-300
-6% -$73.6K 1.82% 12
2022
Q4
$1.39M Sell
5,301
-440
-8% -$118K 2.13% 10
2022
Q3
$1.29M Hold
5,741
1.99% 10
2022
Q2
$1.4M Sell
5,741
-100
-2% -$24.5K 2% 12
2022
Q1
$1.41M Hold
5,841
1.6% 16
2021
Q4
$1.31M Buy
+5,841
New +$1.23M 1.38% 19

Other funds holding AMGN

Lewis Capital Management's AMGN Position: Q3 2023 in Review

Lewis Capital Management increased its Amgen (AMGN) stake by 6.1% in Q3 2023, buying an estimated $74.9K and bringing the position to 5,201 shares worth $1.4M. The position accounts for 2.18% of the portfolio, ranked #8.

Lewis Capital Management first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.41M in Q1 2022. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Lewis Capital Management held 5,201 shares of Amgen worth $1.4M as of Q3 2023.
  • Lewis Capital Management bought 300 Amgen shares in Q3 2023, an estimated $74.9K.
  • Amgen made up 2.18% of Lewis Capital Management's portfolio in Q3 2023, its #8 holding.
  • Lewis Capital Management first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
  • Lewis Capital Management's Amgen position peaked at $1.41M in Q1 2022.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Lewis Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.